Notice of Clarification of Application Types Allowed for RFA-DK-18-012, Human Islet Research Enhancement Center for the Human Islet Research Network (U24 Clinical Trial Not Allowed)

Notice Number: NOT-DK-18-021

Key Dates
Release Date: August 1, 2018

Related Announcements
RFA-DK-18-012

Issued by
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Purpose

The purpose of this Notice is to clarify the application types allowed for RFA-DK-18-012, Human Islet Research Enhancement Center for the Human Islet Research Network (U24 Clinical Trial Not Allowed). In Section II. Award Information: Application Types Allowed, the first appearance of the word "Renewal" is being deleted. Only renewal grants funded under RFA-DK-13-013 will be accepted under this Funding Opportunity Announcement.  

Currently reads:

Application Types Allowed

New
Renewal

Renewal applications from RFA-DK-13-013. 

The OER Glossary and the SF424 (R&R) Application Guide provide details on these application types.

Revised to read:

Application Types Allowed

New
Renewal applications from RFA-DK-13-013. 

The OER Glossary and the SF424 (R&R) Application Guide provide details on these application types.

All other aspects of this Funding Opportunity Annnouncement remain the same.

Inquiries

Please direct all inquiries to:

Thomas Eggerman, M.D., Ph.D.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 
Telephone: 301-594-8813
Email: eggermant@mail.nih.gov